Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zhejiang Nhu CoSZSE:002001 -1.41%98 Net Margin % is 31.95% as of Jun. 2026, which is 15% above its 10-year median of 27.81. GuruFocus rates SZSE:002001 with a GF Score™ of 98/100 and a GF Value™ of ¥28.59 (Fairly Valued). The stock has 3 warning signs investors should review. Among 961 Drug Manufacturers companies, Zhejiang Nhu Co ranks better than 94.59% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Zhejiang Nhu Co's Net Income for the
three
months ended in Jun. 2026 was ¥2,184 Mil. Zhejiang Nhu Co's Revenue for the
three
months ended in Jun. 2026 was ¥6,835 Mil. Therefore, Zhejiang Nhu Co's net margin for the quarter that ended in Jun. 2026 was 31.95%.
The historical rank and industry rank for Zhejiang Nhu Co's Net Margin % or its related term are showing as below:
SZSE:002001'
s Net Margin % Range Over the Past 10 Years
Min: 17.89 Med: 27.81 Max: 35.46
Current: 29.54
SZSE:002001's Net Margin % is ranked better than 94.59% of 961
companies
in the Drug Manufacturers industry
Industry Median: 5.18
vs SZSE:002001: 29.54
Zhejiang Nhu Co (SZSE:002001) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Zhejiang Nhu Co Net Margin % Related Terms
Zhejiang Nhu Co Net Margin % Historical Data
* Premium members only.
The historical data trend for Zhejiang Nhu Co's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Nhu Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Nhu Co Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Zhejiang Nhu Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Zhejiang Nhu Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Nhu Co (SZSE:002001) has a Net Margin % of 31.95% as of Jun. 2026. Net margin is the ratio of total net income to net sales. View historical data on Zhejiang Nhu Co and its competitors. This is 15% above median its historical median of 27.81. Over the past decade, Zhejiang Nhu Co's Net Margin % has ranged from 17.89 to 35.46. According to the industry distribution chart, Zhejiang Nhu Co ranks #52 out of 961 companies in the Drug Manufacturers industry, placing it in the top 5.4%.
Is Zhejiang Nhu Co's Net Margin % too high?
Zhejiang Nhu Co's current Net Margin % of 31.95% is 15% above median its 10-year median of 27.81. Over the past 10 years, this metric has ranged from a low of 17.89 to a high of 35.46. The Drug Manufacturers industry median Net Margin % is 5.18. Zhejiang Nhu Co's value of 31.95% is 516.8% above this industry median. Based on the distribution chart, Zhejiang Nhu Co ranks #52 out of 961 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Zhejiang Nhu Co has a GF Score™ of 98/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Nhu Co's Net Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Zhejiang Nhu Co ranks #52 out of 961 companies for Net Margin %. This places Zhejiang Nhu Co in the top 5% of its industry — outperforming the majority of peers. The industry median Net Margin % is 5.18. Zhejiang Nhu Co's value of 31.95% is 516.8% above this benchmark. Historically, Zhejiang Nhu Co's own Net Margin % has ranged from 17.89 to 35.46 over the past decade. While the company's 10-year median is 27.81 vs. the industry median of 5.18, Zhejiang Nhu Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.18, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhejiang Nhu Co's current Net Margin % of 31.95% is 516.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Zhejiang Nhu Co and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Nhu Co's current Net Margin % is 31.95%, which is 15% above median its own 10-year median of 27.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Nhu Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Nhu Co (SZSE:002001) is currently considered Fairly Valued. The stock's GF Value™ is ¥28.59, compared to a current price of ¥26.48 — trading 7.4% below its estimated fair value. The current Net Margin % is 31.95%, which is 15% above median its 10-year median of 27.81 and 516.8% above the Drug Manufacturers industry median of 5.18. Zhejiang Nhu Co's overall GF Score™ is 98/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Zhejiang Nhu Co (SZSE:002001), the current Net Margin % is 31.95% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhejiang Nhu Co (SZSE:002001) Overvalued in 2026?
Based on GuruFocus' analysis, Zhejiang Nhu Co stock appears to be undervalued.
The current stock price of ¥26.48 is trading 7.4% below its estimated GF Value™ of ¥28.59.
GuruFocus considers Zhejiang Nhu Co to be Fairly Valued.
Key valuation signals for SZSE:002001:
Net Margin %: 31.95% (15% above median its 10-year median of 27.81)
GF Value™: ¥28.59 vs. price of ¥26.48 (7.4% below fair value)
Industry Position: 516.8% above the Drug Manufacturers median (#52 of 961)
No single metric tells the full story. See the SZSE:002001 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhejiang Nhu Co Ltd is a China-based company engaged in the manufacture and sales of pharmaceuticals, health protection products, pharmaceutical intermediates, fragrances, food additives, and feed additives. The company's active pharmaceutical ingredient products cover various areas such as Cardiovascular, Anti-AIDS, Anti-cancer, and Anti-bacterial, with key products such as Latamoxef Sodium, Flomoxef Sodium, Hydrochloride Moxifloxacin, Artemisinin series, Calcium Keto acid series, Vitamin A/E/D3, and coenzyme Q10, and others. The other business areas are Aroma chemicals, Polymers, and Nutrition. The organization markets its products in China and internationally.
98GF Score
Get the complete analysis for SZSE:002001
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:002001 has been successfully added to your 
